Brian Novack

Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York.

Charlesson LLC engages in the development of therapeutics for treating debilitating ophthalmic diseases. The firm product pipeline includes pharmaceutical treatments for age-related macular degeneration, diabetic retinopathy, ocular inflammation, angiogenesis, and systemic diabetes. The company was founded by Jian-Xing Ma and Yan Feng in 2003 and is headquartered in Oklahoma City, OK.

Steba Biotech NV is a Dutch company that manufactures cancer drugs. The CEO of the private company is Yehoshua Shemer.

Vision Technologies Ltd. develops software for wearable devices that has the potential to transform the lives of blind and visually impaired. The company was founded by Stanislav Karpenko in June 2014 and is headquartered in London, the United Kingdom.

Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA.

Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC.